nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—HDAC2—RNA Polymerase I Transcription Initiation—ERCC6—age related macular degeneration	0.0501	0.0501	CbGpPWpGaD
Oxtriphylline—HDAC2—HDACs deacetylate histones—REST—age related macular degeneration	0.0408	0.0408	CbGpPWpGaD
Oxtriphylline—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0259	0.0259	CbGpPWpGaD
Oxtriphylline—HDAC2—RNA Polymerase I Promoter Clearance—ERCC6—age related macular degeneration	0.0259	0.0259	CbGpPWpGaD
Oxtriphylline—HDAC2—RNA Polymerase I Transcription—ERCC6—age related macular degeneration	0.0255	0.0255	CbGpPWpGaD
Oxtriphylline—HDAC2—Factors involved in megakaryocyte development and platelet production—RAD51B—age related macular degeneration	0.021	0.021	CbGpPWpGaD
Oxtriphylline—HDAC2—Chromatin modifying enzymes—REST—age related macular degeneration	0.0209	0.0209	CbGpPWpGaD
Oxtriphylline—HDAC2—RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription—ERCC6—age related macular degeneration	0.0203	0.0203	CbGpPWpGaD
Oxtriphylline—CYP1A2—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0155	0.0155	CbGpPWpGaD
Oxtriphylline—HDAC2—Direct p53 effectors—TNFRSF10A—age related macular degeneration	0.0145	0.0145	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.0144	0.0144	CbGpPWpGaD
Oxtriphylline—ADORA2A—HIF-2-alpha transcription factor network—KDR—age related macular degeneration	0.0141	0.0141	CbGpPWpGaD
Oxtriphylline—HDAC2—Transcription—ERCC6—age related macular degeneration	0.0138	0.0138	CbGpPWpGaD
Oxtriphylline—ADORA1—G alpha (i) signalling events—RHO—age related macular degeneration	0.0132	0.0132	CbGpPWpGaD
Oxtriphylline—HDAC2—p75 NTR receptor-mediated signalling—SQSTM1—age related macular degeneration	0.013	0.013	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—F13B—age related macular degeneration	0.0124	0.0124	CbGpPWpGaD
Oxtriphylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.0124	0.0124	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.0123	0.0123	CbGpPWpGaD
Oxtriphylline—SLC22A7—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0118	0.0118	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—SERPING1—age related macular degeneration	0.0117	0.0117	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—F13B—age related macular degeneration	0.0113	0.0113	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—SERPING1—age related macular degeneration	0.0106	0.0106	CbGpPWpGaD
Oxtriphylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.0105	0.0105	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—RAD51B—age related macular degeneration	0.0101	0.0101	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00948	0.00948	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR ligand binding—RHO—age related macular degeneration	0.00942	0.00942	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—SLC16A8—age related macular degeneration	0.00939	0.00939	CbGpPWpGaD
Oxtriphylline—ADORA1—Circadian rythm related genes—CST3—age related macular degeneration	0.00937	0.00937	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—RAD51B—age related macular degeneration	0.0092	0.0092	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—F13B—age related macular degeneration	0.00902	0.00902	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—SLC16A8—age related macular degeneration	0.00855	0.00855	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—SERPING1—age related macular degeneration	0.00848	0.00848	CbGpPWpGaD
Oxtriphylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00812	0.00812	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR ligand binding—RHO—age related macular degeneration	0.00801	0.00801	CbGpPWpGaD
Oxtriphylline—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—age related macular degeneration	0.00779	0.00779	CbGpPWpGaD
Oxtriphylline—HDAC2—Circadian rythm related genes—CST3—age related macular degeneration	0.00778	0.00778	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—RAD51B—age related macular degeneration	0.00736	0.00736	CbGpPWpGaD
Oxtriphylline—ADORA2A—Circadian rythm related genes—CST3—age related macular degeneration	0.00724	0.00724	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—SLC16A8—age related macular degeneration	0.00684	0.00684	CbGpPWpGaD
Oxtriphylline—SLC22A7—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00672	0.00672	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—RHO—age related macular degeneration	0.00618	0.00618	CbGpPWpGaD
Oxtriphylline—SLC22A7—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00599	0.00599	CbGpPWpGaD
Oxtriphylline—SLC22A7—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00599	0.00599	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—RHO—age related macular degeneration	0.00583	0.00583	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—RHO—age related macular degeneration	0.00532	0.00532	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—RHO—age related macular degeneration	0.0053	0.0053	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—RHO—age related macular degeneration	0.00516	0.00516	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—RDH8—age related macular degeneration	0.00511	0.00511	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—RHO—age related macular degeneration	0.00508	0.00508	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—RHO—age related macular degeneration	0.00483	0.00483	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—RHO—age related macular degeneration	0.00483	0.00483	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling by NGF—SQSTM1—age related macular degeneration	0.00478	0.00478	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—RHO—age related macular degeneration	0.0047	0.0047	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NMNAT1—age related macular degeneration	0.0047	0.0047	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—RDH8—age related macular degeneration	0.0047	0.0047	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—RHO—age related macular degeneration	0.00469	0.00469	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—RDH8—age related macular degeneration	0.00466	0.00466	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—RHO—age related macular degeneration	0.00461	0.00461	CbGpPWpGaD
Oxtriphylline—CYP1A2—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00455	0.00455	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—RHO—age related macular degeneration	0.00453	0.00453	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—RDH8—age related macular degeneration	0.00452	0.00452	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—RHO—age related macular degeneration	0.00447	0.00447	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—RPE65—age related macular degeneration	0.00446	0.00446	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—RDH8—age related macular degeneration	0.00445	0.00445	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by NGF—SQSTM1—age related macular degeneration	0.00444	0.00444	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—RHO—age related macular degeneration	0.00439	0.00439	CbGpPWpGaD
Oxtriphylline—ADORA1—G alpha (i) signalling events—C3—age related macular degeneration	0.00428	0.00428	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—RHO—age related macular degeneration	0.00427	0.00427	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—RDH8—age related macular degeneration	0.00423	0.00423	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—RDH8—age related macular degeneration	0.00412	0.00412	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—RHO—age related macular degeneration	0.00411	0.00411	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—RPE65—age related macular degeneration	0.00411	0.00411	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—RPE65—age related macular degeneration	0.00407	0.00407	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—RHO—age related macular degeneration	0.00406	0.00406	CbGpPWpGaD
Oxtriphylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.004	0.004	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—RDH8—age related macular degeneration	0.00396	0.00396	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—RPE65—age related macular degeneration	0.00395	0.00395	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—RDH8—age related macular degeneration	0.00392	0.00392	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—RPE65—age related macular degeneration	0.00389	0.00389	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—ERCC6—age related macular degeneration	0.00384	0.00384	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—RPE65—age related macular degeneration	0.0037	0.0037	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—RPE65—age related macular degeneration	0.0036	0.0036	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—ABCA4—age related macular degeneration	0.0036	0.0036	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00357	0.00357	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—RHO—age related macular degeneration	0.0035	0.0035	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—RPE65—age related macular degeneration	0.00346	0.00346	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—RPE65—age related macular degeneration	0.00342	0.00342	CbGpPWpGaD
Oxtriphylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.0034	0.0034	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—ABCA4—age related macular degeneration	0.00331	0.00331	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—RDH8—age related macular degeneration	0.00329	0.00329	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—ABCA4—age related macular degeneration	0.00328	0.00328	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—ABCA4—age related macular degeneration	0.00318	0.00318	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—RHO—age related macular degeneration	0.00317	0.00317	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—ABCA4—age related macular degeneration	0.00313	0.00313	CbGpPWpGaD
Oxtriphylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00313	0.00313	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—RHO—age related macular degeneration	0.00313	0.00313	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—RDH8—age related macular degeneration	0.00306	0.00306	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR ligand binding—C3—age related macular degeneration	0.00305	0.00305	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—ABCA4—age related macular degeneration	0.00298	0.00298	CbGpPWpGaD
Oxtriphylline—SLC22A7—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00296	0.00296	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—ABCA4—age related macular degeneration	0.0029	0.0029	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—RHO—age related macular degeneration	0.00288	0.00288	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—RPE65—age related macular degeneration	0.00288	0.00288	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—RHO—age related macular degeneration	0.00286	0.00286	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—ABCA4—age related macular degeneration	0.00279	0.00279	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—CD36—age related macular degeneration	0.00279	0.00279	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—RHO—age related macular degeneration	0.00277	0.00277	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—ABCA4—age related macular degeneration	0.00276	0.00276	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—RHO—age related macular degeneration	0.00272	0.00272	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—RPE65—age related macular degeneration	0.00267	0.00267	CbGpPWpGaD
Oxtriphylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00266	0.00266	CbGpPWpGaD
Oxtriphylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00263	0.00263	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—RHO—age related macular degeneration	0.00259	0.00259	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR ligand binding—C3—age related macular degeneration	0.00259	0.00259	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—CD36—age related macular degeneration	0.00254	0.00254	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—RHO—age related macular degeneration	0.00252	0.00252	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—RHO—age related macular degeneration	0.00243	0.00243	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—RHO—age related macular degeneration	0.0024	0.0024	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00238	0.00238	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ABCA4—age related macular degeneration	0.00232	0.00232	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00216	0.00216	CbGpPWpGaD
Oxtriphylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00205	0.00205	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—CD36—age related macular degeneration	0.00203	0.00203	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR ligand binding—CCL2—age related macular degeneration	0.00203	0.00203	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—RHO—age related macular degeneration	0.00202	0.00202	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—C3—age related macular degeneration	0.002	0.002	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—C3—age related macular degeneration	0.00189	0.00189	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—RHO—age related macular degeneration	0.00187	0.00187	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—CST3—age related macular degeneration	0.0018	0.0018	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TGFBR1—age related macular degeneration	0.00176	0.00176	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—C3—age related macular degeneration	0.00172	0.00172	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—C3—age related macular degeneration	0.00171	0.00171	CbGpPWpGaD
Oxtriphylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.0017	0.0017	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—C3—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—C3—age related macular degeneration	0.00164	0.00164	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—TGFBR1—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.0016	0.0016	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—SQSTM1—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—C3—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—C3—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TGFBR1—age related macular degeneration	0.00153	0.00153	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—C3—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—C3—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—C3—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—C3—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TGFBR1—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—C3—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—C3—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TGFBR1—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—SQSTM1—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SQSTM1—age related macular degeneration	0.00139	0.00139	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—C3—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TGFBR1—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—CCL2—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—C3—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Oxtriphylline—PDE3B—Hemostasis—VEGFA—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SQSTM1—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—C3—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SQSTM1—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SQSTM1—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—CCL2—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SQSTM1—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Oxtriphylline—PDE3A—Hemostasis—VEGFA—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—CCL2—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—CCL2—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TGFBR1—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—C3—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—CCL2—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—CCL2—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—CCL2—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—CCL2—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SQSTM1—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—C3—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—C3—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—VEGFA—age related macular degeneration	0.000966	0.000966	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000954	0.000954	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—APOE—age related macular degeneration	0.000942	0.000942	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—C3—age related macular degeneration	0.000923	0.000923	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—KDR—age related macular degeneration	0.000923	0.000923	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—C3—age related macular degeneration	0.000896	0.000896	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000887	0.000887	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—C3—age related macular degeneration	0.000881	0.000881	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—APOE—age related macular degeneration	0.000867	0.000867	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—APOE—age related macular degeneration	0.00086	0.00086	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—KDR—age related macular degeneration	0.000842	0.000842	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—C3—age related macular degeneration	0.000838	0.000838	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—APOE—age related macular degeneration	0.000834	0.000834	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000822	0.000822	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—APOE—age related macular degeneration	0.00082	0.00082	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—KDR—age related macular degeneration	0.000817	0.000817	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—C3—age related macular degeneration	0.000816	0.000816	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—KDR—age related macular degeneration	0.000803	0.000803	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000803	0.000803	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000793	0.000793	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CCL2—age related macular degeneration	0.000792	0.000792	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—C3—age related macular degeneration	0.000785	0.000785	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—APOE—age related macular degeneration	0.000781	0.000781	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—C3—age related macular degeneration	0.000776	0.000776	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—KDR—age related macular degeneration	0.000765	0.000765	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—APOE—age related macular degeneration	0.000759	0.000759	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—KDR—age related macular degeneration	0.000744	0.000744	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—APOE—age related macular degeneration	0.000731	0.000731	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CCL2—age related macular degeneration	0.000723	0.000723	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—APOE—age related macular degeneration	0.000722	0.000722	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—KDR—age related macular degeneration	0.000716	0.000716	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000715	0.000715	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—KDR—age related macular degeneration	0.000708	0.000708	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CCL2—age related macular degeneration	0.000701	0.000701	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CCL2—age related macular degeneration	0.000689	0.000689	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CCL2—age related macular degeneration	0.000656	0.000656	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—C3—age related macular degeneration	0.000652	0.000652	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCL2—age related macular degeneration	0.000638	0.000638	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCL2—age related macular degeneration	0.000614	0.000614	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCL2—age related macular degeneration	0.000607	0.000607	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—APOE—age related macular degeneration	0.000607	0.000607	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—C3—age related macular degeneration	0.000606	0.000606	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—KDR—age related macular degeneration	0.000595	0.000595	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—APOE—age related macular degeneration	0.000564	0.000564	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—KDR—age related macular degeneration	0.000553	0.000553	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCL2—age related macular degeneration	0.00051	0.00051	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—VEGFA—age related macular degeneration	0.000508	0.000508	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000477	0.000477	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000474	0.000474	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000464	0.000464	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VEGFA—age related macular degeneration	0.00045	0.00045	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VEGFA—age related macular degeneration	0.000443	0.000443	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VEGFA—age related macular degeneration	0.000421	0.000421	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000421	0.000421	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VEGFA—age related macular degeneration	0.00041	0.00041	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VEGFA—age related macular degeneration	0.000395	0.000395	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VEGFA—age related macular degeneration	0.00039	0.00039	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000366	0.000366	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000353	0.000353	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VEGFA—age related macular degeneration	0.000328	0.000328	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000305	0.000305	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000212	0.000212	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000187	0.000187	CbGpPWpGaD
